Karyopharm Therapeutics: Q2 Earnings Snapshot

    NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $67 million in its second quarter.

    The Newton, Massachusetts-based company said it had a loss of $2.32 per share.

    The pharmaceutical company posted revenue of $33.4 million in the period.

    Karyopharm Therapeutics expects full-year revenue in the range of $130 million to $150 million.

    _____

    This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI

    Source

    Latest Posts